Lilly's Ebglyss delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis: Indianapolis Monday, March 30, 2026, 12:00 Hrs [IST] ...
UCB, a global biopharmaceutical company, today announced new data in moderate-to-severe plaque psoriasis (PSO) at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, March 27–31.
EBGLYSS (lebrikizumab-lbkz) delivered durable skin clearance and relief from persistent itch for up to four years for ...
As cities worldwide accelerate toward electrification and decarbonization, the convergence of distributed energy resources and electric mobility is ...
Rising prices during the Ukraine energy crisis in 2022 and 2023 are still fresh in people's minds. When bills went through the roof, it drove the first wave of solar deployment.
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasisResults ...
The Pakistan Stock Exchange (PSX) observed selling pressure on Thursday, with the KSE-100 Index shedding nearly 5,000 points ...
Here’s the latest on the Pearson gold heist mastermind’s guilty plea in court and Prime Minister Mark Carney and Ontario ...
Frequent travel lifestyle impacts health, productivity, and balance. Learn how professionals manage stress, sleep, and ...
State Rep. Justin Pearson criticized the president for coming to the Bluff City.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results